Soligenix Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.36

+0.05 (+17.15%)

As of May 16, 2:30 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +11,154.1% upside

Low Target $24.77

Average Target $40.83

High Target $47.84

Current Price $0.36

Current
$0.36

Target
$40.83

$24.77 $40.83 avg $47.84

Scenario Analysis

Bear Case

$24.77

6,727.5%

Low target

Base Case

$40.83

+11,154.1%

Avg target

Bull Case

$47.84

+13,086.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.23

-94.2% from high

52-Week Low

$0.28

+29.6% from low

Target vs 52W High

$40.83

+555.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%